ClearPoint Neuro, Inc. CLPT
ClearPoint Neuro, Inc. (Nasdaq: CLPT) is a CNS/neurology/psychiatry medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| ClearPoint Neuro Navigation System | Neurosurgical navigation / drug and cell delivery | — | NA_NON_THERAPEUTIC |
| IRRAS neurocritical care products (IRRAflow etc.) | Intracranial hemorrhage / fluid management | — | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other CNS/neurology/psychiatry companies
- Brainsway Ltd. BWAY
- NeuroPace Inc NPCE
- Mobia Medical, Inc. MOBI
- Neuronetics, Inc. STIM
- NEUROONE MEDICAL TECHNOLOGIES Corp NMTC
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.